Research & Clinical Trials
For more than 30 years, Carle has advanced medicine by offering patients access to treatment options known as clinical trials. These research initiatives offer new insight into how to combat a disease, demonstrate new ways of thinking about treatment, and possible cures. Other clinical trials target treatment side effects and cancer prevention.
Currently, Carle is participating in more than 70 clinical trials for a variety of conditions. All participants must meet eligibility requirements and give written consent prior to enrolling. If you are interested in taking part in a clinical trial, contact your physician or the cancer research group at Carle at (217) 383-3516.
View current clinical trials
Kendrith Rowland, MD: Principal Investigator
As director of Cancer Research at Carle, Dr. Kendrith Rowland has dedicated countless hours to the program's success, educating physicians and staff on new protocol opportunities, quality initiatives and clinical trial development. He is principal investigator for Carle's longstanding National Cancer Institute Community Clinical Oncology Program grant, and he and his team were recognized by the NCI for enrolling more than 100 patients to prevention, symptom management and cancer treatment trials each year. Dr. Rowland's efforts have led to decades of federal funding for research at Carle, and to new cancer treatments that have improved the standard of care for patients in our community.